Retraction
A subset of PARP inhibitors induces lethal telomere fusion in ALT-dependent tumor cells
Paper Information
Record ID:
38886
Author(s):
Journal:
Publication Date:
May 21, 2021
Retraction Date:
September 07, 2022
(3.2 years years ago)
Subjects:
Institutions:
- Department of Neurosurgery and The Brain Tumor Center, University of California–San Francisco, San Francisco, CA 94158, USA
- Core Diagnostics, 3535 Breakwater Avenue, Hayward, CA 94545, USA
- Department of Integrative Biology, University of California–Berkeley, Berkeley, CA 94720, USA
- The Kristian Gerhard Jebsen Brain Tumor Research Centre, Department of Biomedicine, University of Bergen, Jonas Lies Vei 91, 5019, Bergen, Norway
- Department of Neurosurgery, Fujita Health University, Toyoake 4701192, Aichi, Japan
- Department of Oncology, Luxembourg Institute of Health, 84, Val Fleuri, L-1526, Luxembourg
Countries:
Article Type:
Publisher:
American Association for the Advancement of Science (AAAS)
Open Access:
Yes
PubMed ID:
Retraction PubMed ID:
Retraction Details
Retraction Reasons:
Nature of Retraction:
Retraction
Retraction Notice:
10.1126/scitranslmed.ade6609Additional Notes:
see also: https://pubpeer.com/publications/63785A5F6687D57EA4035298E41269#1
Citations (11)
11
Total Citations2
Post-Retraction(18.2%)
8
Pre-Retraction1
Same DayPost-Retraction Citation Analysis
0
Within 30 days
0
Within 1 year
0
After 2+ years
482
Days since retraction (latest)
The ALT pathway generates telomere fusions that can be detected in the blood of cancer patients
Francesc Muyas, Manuel J. Gómez, Rita Cascão et al. (8 authors)
Nature Communications
Open Access
Published: Jan 2024
5 citations
5 citations
482 days after retraction
The Altered Functions of Shelterin Components in ALT Cells
Yanduo Zhang, Kailong Hou, Jinkai Tong et al. (7 authors)
International Journal of Molecular Sciences
Open Access
Published: Nov 2023
9 citations
9 citations
446 days after retraction
Retraction
H. Holden Thorp, Orla Smith
Science Translational Medicine
Published: Sep 2022
Same day as retraction
Translational significance of CDKN2A/B homozygous deletion in isocitrate dehydrogenase-mutant astrocytoma
Shannon P. Fortin Ensign, Robert B. Jenkins, Caterina Giannini et al. (6 authors)
Neuro-Oncology
Open Access
Published: Aug 2022
22 citations
22 citations
21 days before retraction
Targeting telomeres: advances in telomere maintenance mechanism-specific cancer therapies
Jixuan Gao, Hilda A. Pickett
Nature reviews. Cancer
Published: Jul 2022
151 citations
151 citations
64 days before retraction
New twists to the ALTernative endings at telomeres
Ragini Bhargava, Michelle Lee Lynskey, Roderick J. O’Sullivan
DNA repair
Open Access
Published: May 2022
25 citations
25 citations
117 days before retraction
Alternative Lengthening of Telomeres and Mediated Telomere Synthesis
Kailong Hou, Yuyang Yu, Duda Li et al. (8 authors)
Cancers
Open Access
Published: Apr 2022
15 citations
15 citations
133 days before retraction
Consequences of telomere replication failure: the other end-replication problem
Kirsten Ann Brenner, Jayakrishnan Nandakumar
Trends in Biochemical Sciences
Open Access
Published: Apr 2022
23 citations
23 citations
144 days before retraction
The ALT pathway generates telomere fusions that can be detected in the blood of cancer patients
Francesc Muyas, Manuel J. Gómez, Isidro Cortés‐Ciriano et al. (4 authors)
bioRxiv (Cold Spring Harbor Laboratory)
Open Access
Published: Jan 2022
2 citations
2 citations
222 days before retraction
Deuterium magnetic resonance spectroscopy enables noninvasive metabolic imaging of tumor burden and response to therapy in low-grade gliomas
Céline Taglang, Georgios Batsios, Joydeep Mukherjee et al. (10 authors)
Neuro-Oncology
Open Access
Published: Jan 2022
16 citations
16 citations
225 days before retraction
MRE11 and UBR5 Co-Operate to Suppress RNF168-Mediated Fusion of Dysfunctional Telomeres
Yongjian Tang, Joydeep Mukherjee, Russell O. Pieper
Frontiers in Oncology
Open Access
Published: Nov 2021
2 citations
2 citations
289 days before retraction
Quick Stats
Total Citations:
11
Years Since Retraction:
3.2 years
Open Access:
Yes
Last Checked:
Jul 24, 2025